1. Introduction
The sweet chestnut tree (
Castanea sativa Mill.), which belongs to the Fagaceae family, is widely distributed in European countries, Italy, Spain, France, Greece, Portugal and Turkey for wood, fruit, honey as tannins source [
1,
2]. Over the last decade, the chestnut sector has constantly grown in Europe, since fruits, mainly consumed boiled or roasted, are an excellent source of energy, due to their high starch content, minerals (K, Mg, Mn, and Cu), unsaturated fatty acids (omega-3), fiber and vitamins E and C [
3,
4]. A variety of preparations have been added to the traditional use of the fruit: marron glacé, purées, frozen nuts, and jams, and, more recently, different gluten-free products based on chestnut flour for celiac patients [
5,
6].
Burs, leaves and the residue of chestnut processing generates a large amount of waste material, about the 15% of the total production. Inner and outer shell resulting from chestnut peeling, represent about 20% of the total fruit weight [
5]. This residue, habitually burned as fuel in factories, is the target of new strategies of value assessment and reuse: heavy metal absorbents or wood adhesives, raw materials for lignin and bioethanol production and pigment source for dyeing [
7,
8]. At present, there are new attractive applications for utilizing chestnut waste as a source of bioactive compounds with healthy effects [
9]; the chestnut pericarp (outer shell; husk) and integument (inner shell; pellicle) are a rich source of nutraceuticals, ascorbic acid, carotenoids, phenolics like gallic and ellagic acid, flavonoids and condensed tannins, with antioxidant, antimicrobial, and anticancer properties [
4,
10,
11,
12]. The
green recovery of these bioactive compounds from chestnut shell becomes decisive, both to preserve their healthy properties for food, cosmetics and pharmaceutical industries and, not less important, to reduce the environmental impact of organic solvents [
6]. Hence the decision to use, in this work, only deionized water as an extractant of phenolic compounds. Cold and hot water, alone or in combinations with organic solvents, has been employed by our group, with different purposes and on different matrices, since 2010 [
13,
14,
15,
16,
17,
18], but this work is the first on chestnut. Other researchers used cold water with Na
2SO
3 and NaOH to extract phenolic compounds, tannins and ellagitannins from Portuguese chestnut peels [
19]; bur and shell extracts of
Castanea sativa were obtained using water and hydroalcoholic solutions at 25, 50 and 75 °C to make the extraction faster, selective, and more effective [
20]; Jung et al. [
21] used water and a variety of organic solvents, at 60 °C, to extract polyphenols from inner shells of Japanese chestnut (
Castanea crenata); boiling water aimed at maximizing the recovery of bioactive compounds from inner and outer shells of Italian chestnut [
22,
23]. The use of water alone as a solvent is expected to provide extracts with lower yield of phenolic compounds than organic solvents or hydroalcoholic mixtures [
20]. The chemical composition of these extracts, their antioxidant and antitumoral properties, that are the subject of this research, are also expected to change [
20,
21,
24]. In this work, the antioxidant capacity of chestnut extracts has been quantified with analytical systems such as DPPH and ABTS, spectrophotometric tests capable of indirectly measuring, with a single assay, the sum of the antioxidant activities of a pool of molecules [
25]. A direct electrochemical determination of antioxidants was also provided according to recent studies on outer shell extracts [
26] and other plant and fruit extracts [
27,
28]; the redox properties of single molecules, such as gallic, ellagic and tannic acid, were also investigated [
29,
30]. Since the phenolic compounds can be easily oxidized on carbon electrodes [
31,
32,
33], and their ionization potential determines their efficiency as antioxidants [
34,
35], the cyclic voltammetry (CV) was used to show the potential at which the oxidation starts and to provide a measure of antioxidant capacity [
17].
Various researches, over the last 20 years, have provided a characterization of the phenolic compounds present in chestnut shell extracts, attributing them antioxidant and anti-tumor properties [
36,
37,
38]. Although there's a general concern in indicating the polyphenolic fraction of various chestnut organs responsible for anti-tumor action [
12,
21,
39], even in this case it is yet to be established which molecules are actually responsible and which are not. Moreover, there is some evidence that the same molecules that perform antioxidant activity at certain concentrations act as pro-oxidants at others [
17]. Chestnut extracts, derived from flesh and inner- and outer-shell, induced apoptosis in human gastric cancer cells [
36]; apoptosis was also induced by chestnut honey on prostate cancer cells [
40], by bark extracts on neuroblastoma cells [
41], and by shell extracts on prostate, breast and hepatocellular cancer cells [
12]. In this work, we tried to understand how the extraction method could affect the extraction yield of some compounds with presumed anti-tumor activity in different chestnut accessions of Sardinian biodiversity, and then we focused on the ability of the different extracts to inhibit the growth of cells belonging to different tumor lines.
3. Discussion
This work aimed to investigate some healthy properties of polyphenolic waste extracts obtained with sustainable and eco-friendly methods for industrial applications. The research focused on water extracts of outer shell of four chestnut accessions and one marron variety, with emphasis on their phenolic composition, antioxidant activity and antiproliferative effect on normal cells (fibroblasts), and on two colon (RKO and SW48), one breast (MCF7) and one melanoma (B16F10) cancer cell lines.
The extraction of phenolic compounds from plant materials has been carried out with organic solvents (methanol, ethanol, acetone, etc.) for years, and it was the same for the chestnut [
48,
49]. Vasquez et al. [
50] compared the yields resulting from different extraction methods, with organic solvents (96% n-hexane, acetone, ethyl acetate, ethanol and methanol), with water or with a 2.5% Na
2SO
3 aqueous solution heated to 90 °C for one hour: the yield of extractable compounds increased with the polarity of the solvent and the highest yield corresponded to water. The same authors, studying the influence of extraction conditions (water and different alkaline solutions at 70 and 90 °C) observed an increase of total phenols and antioxidant activity when the temperature increased. The use of water alone or combined in hydroalcoholic solutions is more recent [
19,
20,
22,
23], and there are green technologies, like subcritical water extraction, used to maximize the extraction yield and polyphenol content [
51], which offer a more economically sustainable and environmentally friendly alternative for large-scale industrial applications. In this work, we took into account previous results which demonstrated that the use of hot water, for the same extraction time, increased the extraction capacity of the solvent [
20]. The use of hot water has two important critical issues: first, heating the water has a cost for industries; second, the thermolabile phenolic component is affected [
51]. We have shown that this is not always true, at least in terms of yield of total polyphenols, flavonoids and tannins: the extracts from the four Sardinian accessions contained statistically non-different quantities of TP, TF and CT after 4 hours of extraction in cold water or one hour of extraction in hot water at 95 °C. For marron the results were different, and hot water proved to be able to extract a greater quantity of total polyphenols and condensed tannins than cold water, but not of flavonoids.
The DPPH and ABTS tests for antioxidant capacity determination seemed to mirror the analytical tests for TP, TF and CT. No significant differences were determined by the extraction at different temperatures for MURG, LOCG and ILDP accessions, while a higher antioxidant activity was measured for COEV and MARRV extracts at 95 °C. The electrochemical tests, however, showed a different trend: the antioxidant capacity of MURG extracts was higher at 20 °C, the one of LOCG and MARRV was higher at 95 °C, and ILDP and COEV did not statistically differ. A comparison between DPPH assay and CV cyclic voltammetry can be found in a previous study [
26]: what the two works have in common, and which gives us the possibility of having a valid term of comparison, is the threshold of +0.5 V established a priori in order to discriminate the real antioxidant capacity of the extracts. Ricci's group attributes two important limitations to the DPPH assay, long incubation times and difficulties with colored samples: we completely agree and, furthermore, we also believe that the DPPH and ABTS assays tend to overestimate the antioxidant capacity because they take into account species in solution, which oxidize at a potential greater than +0.5 V [
34]. Fadda and Sanna [
52], in a dissertation on advantages and pitfalls of methods for antioxidant activity evaluation, affirmed that the capacity of antioxidants to reduce the radical cation ABTS
•+ to ABTS is directly related to the reduction potential of the antioxidants, and only those with
E0 values lower than that of the couple ABTS
•+/ABTS (
E0 = 0.68 V) are able to perform this reduction. Obtaining a good correlation between spectrophotometric and electrochemical methods is possible if similar trends are observed, but this does not mean that comparable antioxidant capacity values are obtained. The antioxidant capacity of the outer shell extracts is linked to the concentration of phenolic compounds able of oxidizing at E
app lower than +0.5 V but, in the absence of a mass spectrometric analysis, we do not have the complete profile of all molecules in the investigated accessions, nor do we know their specific reducing power. According to our HPLC analysis, we can state that all seven compounds identified and quantified have a redox potential lower than +0.4 V and that all of them contributed to the antioxidant capacity according to their concentration in the extracts. Even though the obtained qualitative phenolic profile was similar to that reported by other authors, differences in quantitative content was found [
4,
39,
42]: TP values similar to our MARVV and lower than those of Sardinian accessions, but with shorter extraction times were recorded by De Vasconcelos et al. [
4], while CT values were comparable to our results. A content of TP approximately ten-fold higher than ours was found in chestnut waste consisting of inner and outer shell water extract [
24]. This high variability assessed in the literature could be attributed to varietal differences, although a wide number of factors influence the phytochemical levels in vegetal matrices, such as geographical origin, pedoclimatic conditions, irrigation, seasonality etc. Beyond all this, the role of temperature must be considered. The HPLC analysis showed that the temperature distinguishes between the different molecules: the ellagic acid showed the highest concentration in the cold extracts, ellagitannins in the hot ones and, for the other molecules, specific cultivar-dependent trends were recorded. Vella et al. [
23] found a TP and FC content much lower than ours in water extract at boiling temperature (for 40 min) of outer shell chestnut Campania cultivars. An increase in the castalagin and gallic acid concentration, consequence of an increase in the extraction temperature, was reported by De Vasconcelos et al. [
4] as for our cultivar MARRV. The thermal stability at 60, 80 and 100 °C of water solutions of gallic acid, catechin, and vanillic acid was studied: it was demonstrated that the degradation of the phenolic compounds in grape seeds and spruce bark vegetal extracts was lower, for all the temperatures, than individual standard solutions, confirming that the complex chemical composition of vegetal extracts has to take into account to evaluated thermal stability of phenolic compounds [
53]. It was reported that high temperature and long extraction times can promote the phenols oxidations and reduce antioxidant properties [
7], that temperatures up to 90 °C increase the extraction of phenolic compounds [
4,
23,
54], and that this increase is not always associated with the maximum antioxidant capacity [
20] due to additive and synergic effects of individual phytochemicals.
All the considerations made so far are based on in vitro studies, chemical and electrochemical tests, but to better understand the role of phenolic compounds their biological activity on normal and cancer cells has been investigated. It is known that polyphenols decrease DNA damage induced by various carcinogens acting as ROS scavengers, chelating transition metals, or modulating the expression and the activity of the enzymes related to oxidative stress [
55]. The antioxidant activity of polyphenols could be essential but not sufficient for chemoprevention [
56] and there is evidence that naturally occurring antioxidants elicit different redox responses according to a dose-response mechanism and the intracellular redox state [
57,
58,
59].
As many other species, the chestnut phenolic compounds have been correlated with anticancer activity. Unfortunately, studies on the anticancer properties of chestnut are still limited to a few articles: one tumor (DU 145) and one normal prostate epithelial (PNT2) cell line were exposed to increasing concentration of shell polyphenols extracts, thus showing an increase of apoptotic cells after 48 and 72 h treatments [
12]; anticancer activity vs. prostate cancer cells (DU 145 and PC3) was attributed to a quinoline-pyrrolidine alkaloid present in chestnut honey, and the inhibition of clonogenic activity was congruent with apoptotic events [
40]. Apoptotic-induced effects were also observed on neuroblastoma cells (SH-SY5Y) when exposed to increasing concentration extract obtained by bark of
Castanea sativa containing high amounts of vescalagin, castalagin gallic and ellagic acid [
41].
In our work, normal cells and four cancer cell lines, SW48, RKO, MCF7 and B16F10, were exposed to cold and hot water pericarp extracts of four Sardinian accessions and of one marron cultivar. The temperature and different extraction times significantly influenced the growth of cells, both normal and tumor. The fibroblast viability was significantly reduced, at least by 20%, by treatments with cold extracts starting from 100 µg/ml of MURG and COEV, 50 µg/ml of LOCG and ILDP, and even 10 µg/ml of MARRV. According to Floris et al. [
60], a 20% reduction in viability is the threshold to consider a treatment to be effective. Such a reduction, with hot extracts, was observed only with doses greater than 250 µg/ml, regardless of the accession or cultivar to which they belong. This clearly indicates that the pool of molecules extracted at 95 °C exerts a cytotoxic effect significantly lower than that of cold extracts. Even on cancer cells, the most evident cytotoxic effects were observed when the cells were treated with the cold extracts.
The viability of metastatic colon cancer cells, SW48 and RKO, was strongly reduced by 100 µg/ml (if not even 50 µg/ml of LOCG) of all the Sardinian accessions extracts, while MARRV had no effect; also in this case, the cytotoxic action of the hot extracts was decidedly lower, and only at the highest doses. The activity against colon cancer cells of chestnut extracts was also investigated by other research groups. The capacity of inner shell extracts of Japanese chestnut (
Castanea crenata Siebold & Zucc., 1846), to inhibit the viability of LoVo and HT29, two human colon adenocarcinoma cell lines, was explored [
21]: the water extracts (24 h at 60 °C), containing 2.78 mg g
-1 of gallic acid (higher than ours) and 1.07 mg g
-1 of ellagic acid (lower than ours), induced a viability reduction, varying between 20 and 60%, starting from 125 µg/ml, a result comparable to those obtained by our group on RKO and SW48. On the other hand, the bioactive compounds of shells of Chinese chestnut (
Castanea mollissima Blume) seemed to have a moderate anti-cancer activity on human COLO 320 DM colon cancer cells, but results cannot be compared with ours since a 90:10 (v/v) ethanol-water solution was used as extractant [
61].
Treatments on B16F10 melanoma cells resulted less effective: a decrease in viability by cold MURG extracts was induced only by the maximum dose, while the same dose of hot extract increased cell growth. The cold extracts of LOCG, ILDP and COEV also had mild effects, while the hot extracts appeared almost ineffective. The same goes for MARRV, with reduction in cell viability only at the highest dose of hot and cold extract. Unfortunately, we were not able to compare our data with the literature since we did not find any other pertinent study concerning melanoma cancer cells and chestnut derivatives.
A separate discussion must be made for breast cancer MCF7 cells: cold extracts of MURG, LOCG, ILDP and COEV induced a significant increase in cell viability starting from moderate doses (50 µg/ml); hot extracts had a similar, but less evident effect compared to reference fibroblasts. What was surprising, compared with the Sardinian accessions, was the effect induced by the hot extracts of MARRV which induced a reduction in cell viability of approximately 50% at the highest treatment dose. Cacciola et al. [
12], worked with chestnut shell water extract, rich in gallic acid but with a much lower ellagic acid content than that found in our extracts; they observed that treatments with 100 µg/ml of extract induced a significant reduction in the viability of MCF7 cells, but less than 20%, and no effect on MDA-MB-231, another breast cancer cell line. This is in agreement with our results, since MARRV hot extracts were not effective at 100 µg/ml, and became effective only at 250. A similar result, 18% inhibition of cell viability, on the MDA-MB-231 line was obtained by treating the cells for 24 h with doses of 200 µg/ml of chestnut powder [
36]. Finally, a study is worth reporting that suggests that chestnut leaf extracts of
Castanea crenata could increase the susceptibility of MCF7-derived cancer stem cells to paclitaxel, an anticancer drug [
62].
4. Materials and Methods
This study was carried out in "Barbagia" (Nu), an area historically devoted to chestnut cultivation, in the vast mountainous region of central Sardinia which extends along the sides of the "Gennargentu" massif. Samples were collected from four chestnut (
Castanea sativa Miller) accessions of local biodiversity and one Marron variety (
Table 3). MURG, LOCG, ILDP, COEV and MARRV were all harvested
in situ in the municipality of Belvì (39°57′38.19″N 9°11′02.91″E) [
63].
Table 3.
Origin, elevation and harvest time of the chestnut accession and of the marron.
Table 3.
Origin, elevation and harvest time of the chestnut accession and of the marron.
Accession/variety |
Origin |
Elevation (m a.s.l) |
Harvest time |
Acronym |
MIGHELI URRU G |
Belvì |
822 |
October, second decade |
MURG |
LOCCHEDDU G |
Belvì |
812 |
October, second decade |
LOCG |
ILDUBBA P |
Belvì |
849 |
October, second decade |
ILDP |
COESERRA V |
Belvì |
686 |
October, third decade |
COEV |
MARRONE di Marradi V |
Belvì |
780 |
October, second decade |
MARRV |
4.1. Plant Material and Fruit Sampling
Chestnuts were collected at commercial maturity in October 2021. Fruits, free of defects and mechanical damage, were divided in three replicates of 30 chestnuts for each accession. The chestnut pericarp (CP) was manually separated and oven-dried at 40 °C until reaching constant weight, to reduce and standardize the moisture content. The dried samples were ground in a mill to a fine powder (particle sizes 1mm), and stored under vacuum in total darkness, until further analyses.
4.2. Extraction of phenolic compounds
Two different extractions, using water as a solvent, were carried out for the recovery of the bioactive molecules, according to [
12] with some modification:
i) a conventional liquid extraction (CLE) in cold water at 20 °C for 4h. 2.5 grams of CP powder were put in contact with 25 ml of milli-Q water in a thermostatic bath. The liquid and solid phases were separated by centrifugation at 3220× g for 15 minutes. The supernatant was recovered by filtration through a filter paper (Whatman n. 1) under vacuum, while the solid residue was added of another 25 ml. The extraction procedure was repeated, the resulting supernatant was added to the first (solvent/sample final ratio 20:1 (v/w)) and all the liquid was stored at -20 °C until analysis.
ii) a CLE in hot water at 95 °C for 1h. 2.5 g of dried sample were extracted with 50 ml milli-Q water (solvent/sample ratio 20:1 (v/w)), for 1h, under continuous stirring in a thermostatic bath; then the suspension was cooled on ice and centrifuged (15 min at 3220× g). The supernatant was recovered by filtration through a filter paper (Whatman n. 1) under vacuum and stored at -20 °C until analysis.
4.3. Analytical tests
Water extracts were analyzed for, total phenolics (TP), total flavonoids (TF), condensed tannins (CT), individual phenolic compounds and antioxidant capacity.
4.3.1. Determination of total phenolic content
The total phenolic content (TPC) was assessed by Folin-Ciocalteu assay according to previous procedure [
18]. Aliquots of the diluted samples were mixed in a 25 mL volumetric flask with Folin–Ciocalteu reagent (1:1) and a 10 ml sodium carbonate solution 7.5%, and incubated for 2 h at room temperature. TPC was determined by spectrophotometric analysis (8453 UVVisible Spectrophotometer, Agilent Technologies, USA) at an absorbance of 750 nm; it was expressed as milligrams of gallic acid equivalents (GAE) per g of dried matter (DW) referring to a gallic acid calibration curve (10-100 mg l
-1, R
2= 0.990). Samples were analyzed in triplicate.
4.3.2. Determination of total flavonoid content
The total flavonoid content (TFC) was quantified by colorimetric assay according to the AlCl
3 assay and previously reported procedures [
64]. Quantification was carried using a catechin (C) calibration curve (2.5 – 20 µg ml
-1, r
2 = 0.995). Results were expressed as mg of catechin equivalent (CE) x g
-1 of dried matter (mg CE g
-1 DW).
4.3.3. Determination of condensed tannin content
The vanillin assay was used to quantify the extractable condensed tannin content of the samples, according to [
18]. The absorbance of vanillin-tannin adducts was spectrophotometrically detected at 500 nm, and concentrations were calculated referring to a catechin calibration curve (1 – 6 μg ml
-1, R
2 = 0.998). Results were expressed as mg CE g
-1 DW.
4.3.4. Determination of antioxidant capacity by DPPH and ABTS assays
The antioxidant capacity of CP extracts was evaluated by DPPH (1,1-diphenyl-2-picrylhydrazyl) and ABTS (2,2-azinobis (3-ethylbenzothiazoline-6-sulphonic acid) diammonium salt) assays, according to [
65]. Briefly, for each assay, 0.1 mL of appropriately diluted PPE was mixed with 3.9 mL of 60 μM DPPH or 7 mM ABTS, and then stored in the dark for 120 or 6 min, respectively. The Trolox equivalent antioxidant capacity (TEAC), was expressed as mmol Trolox equivalents·100 x g
−1 of dry matter (mmol TEAC·100 g−1 DM).
4.3.5. Determination of antioxidant capacity by electrochemical method
The antioxidant capacity (AAox) determination of the chestnut pericarp extracts was also performed by cyclic voltammetry (CV) as previously reported [
17,
44] with some modifications. Measures were carried out by screen-printed sensors purchased by GSI Technologies (Burr Ridge, IL, USA), consisting of a 4 mm carbon working electrode (WE), an Ag/AgCl pseudo reference electrode (RE), and a carbon auxiliary electrode (AE). Currents were recorded by Quadstat, a commercial four-channel potentiostat (eDaQ Quadstat, e-Corder 410 and Echem software, eDAQ Europe Poland, Warsaw Poland). Cyclic voltammograms (CVs) were performed from −0.2 V to +0.8 V (vs. Ag/AgCl pseudo-RE) at a scan rate of 0.1 V/s. A first aliquot of 70 μL, containing only PBS (used as a supporting electrolyte), was deposited on the screen-printed WE with a graduated micropipette in order to obtain a baseline. Once the baseline current was recorded, the PBS drop was dried with absorbent paper without touching the surface of the sensor, and 70 μL aliquot of 2 mg/ml chestnut outer shell extract solution was deposited on the sensor surface, thus obtaining the corresponding CV pattern (the experiment was performed in triplicate). In order to provide a quantitative comparison among the CV patterns of extracts of different origin, the voltammograms were integrated and the area under curve (AUC) was calculated at +0.5 V and expressed in microcoulombs (μC). The redox potential of +0.5 V is used as a threshold to detect the antioxidant activity of chestnut extracts in accordance with previous studies [
17]. As already reported [
43,
45,
66], oxidation potentials higher than +0.5 V refer to polyphenols with low reducing power which, in this work, were not accounted as antioxidants.
4.4. HPLC analysis of phenolic compounds
Chromatographic separation of phenolic compounds was carried out with reverse-phase HPLC method using an Agilent 1100 Liquid Chromatography (LC) system (Agilent Technologies, Palo Alto, CA, USA) equipped with a quaternary pump (G1311A), degasser, column thermostat, auto-sampler (G1313A), and a diode array detector (G1315 B, DAD). The column was a Luna C18 column (250 x 4.6 mm, 5 µm) from Phenomenex (Torrance, CA, USA) with a security guard cartridge (4 × 2 mm). The flow rate was set at 0.8 ml min
-1, and the column temperature was set to 30 °C. Elution was carried out with a binary mobile phase of solvent A (water and 0.1% trifluoracetic acid) and solvent B (acetonitrile) and the gradient elution program was according to [
18]: 0 min, 99% A; 5 min, 95% A; 6 min, 93% A; 10 min, 85% A; 15 min, 75% A; 20 min, 10% A; 25 min, 99% A, with a post-time of 3 min. Detection was performed at 254, 280, 350, and 360 nm. Phenolic molecules were identified according to the retention time of a mixture of standards, selected from the literature concerning CP phenolic, their UV absorption spectra, as well as by adding standard solutions to the sample composition and quantified using the respective calibration curves. Samples were appropriately diluted before injection. The results are presented as milligrams per gram of dry weight (mg g
-1 DW).
4.5. Cell culture and biological assays
Five different cell lines, obtained from ATCC, had been selected to be tested with cold and hot water chestnut extracts: 1) Human fibroblast (normal cells); 2) B16F10 (murine melanoma cells; N-ras, Braf and p53 wt); 3) MCF7 (human metastatic breast cancer cells, estrogen receptor (ER) +, progesterone receptor (PR)+, epithelial receptor 2 (HER2) -, BRCA1 wt); 4) RKO (human metastatic colon cancer cells; P53, K-ras and PTEN wt, Braf p.V600E, PIK3CA p.H1047R); 5) SW48 (human metastatic colon cancer cells; P53, K-ras and PTEN wt, Braf p.R347Xc, PIK3CA p.G914Rc).
Human fibroblasts, B16F10 and MCF7 were grown in DMEM, RKO cells in EMEM and SW48 in RPMI1640 at 37 °C under humidified 5% CO2/air. All media were completed with 10% FBS, 1% penicillin (100 U mL -1)/streptomycin (100 µg mL-1), and 1% L-glutamine. For experimental studies, cells were plated in 96 well plates at a density of about 2 x 104 mL-1 and, 24 h post seeding, exposed to increasing concentrations of hot and cold extract (10–50-100-250 µg mL-1) for 24 h.
4.5.1. MTT assay
The MTT assay was used to assess the cell viability as previously reported [
17]: cells were incubated with 100 µL (0.05 mg mL
-1) of MTT, and the cultures were allowed to incubate at 37 °C for 3 h. The MTT was removed and the formazan crystals were dissolved in 100 µL of isopropanol. The color was read at 570 nm using a microplate reader (EMax® Plus, Molecular Devices). The percentage of cell growth and metabolic activity was calculated by normalizing the absorbance of the treated cells to corresponding control. All the experiments were done in quadruplicate and repeated at least three times.
4.6. Data Analysis
The statistical analysis was performed by GraphPad Prism 5 for Windows software (Graph-Pad Software, Inc., La Jolla, CA 92037, USA). A two-way ANOVA was used to estimate how the chemical parameters (TP, TF, CT, HPLC quantification of phenols and antioxidant capacity) of the different accessions, changed according to the temperature of extraction (20 °C and 95 °C). Data were reported as mean ± standard deviation (SD). In order to compare means obtained at 20 °C and 95 °C, a Student’s t-test was performed for every parameter within each chestnut accession and for the marron. The level of significance was fixed at p ≤ 0.05.
Biological tests were performed to compare the effects of different extract concentration (0, 10, 50, 100 and 250 µg/ml) on cancer cells, with the effect of the same concentration on fibroblasts. For each accession, a Student's t-test was used to compare the effects of different extract concentration on fibroblasts, setting the significance level at p ≤ 0.01 vs Ctrl. Then, a one-way ANOVA was performed to compare the effects of different extract concentration on cancer cells, setting the significance level at p ≤ 0.01 vs fibroblasts. The mean value ± SE was reported in the figures.
Figure 1.
Cyclic voltammetry, with a scanned potential range (Eapp) comprised between –0.2 V and +0.8 V vs. carbon pseudoreference, in the absence (PBS black line) and in the presence of 2 mg ml−1 of MURG (green line), LOCG (purple line), ILDP (red line), COEV (blue line) and MARRV (yellow line) chestnut pericarp cold water extracts (A) and hot water extracts (B).
Figure 1.
Cyclic voltammetry, with a scanned potential range (Eapp) comprised between –0.2 V and +0.8 V vs. carbon pseudoreference, in the absence (PBS black line) and in the presence of 2 mg ml−1 of MURG (green line), LOCG (purple line), ILDP (red line), COEV (blue line) and MARRV (yellow line) chestnut pericarp cold water extracts (A) and hot water extracts (B).
Figure 2.
Effect of growing concentrations (from 10 to 250 µg/ml) of MURG chestnut pericarp extract on viability of normal cells (fibroblasts), and of colon (SW48 and RKO), breast (MCF7) and melanoma (B16F10) cancer cells. # = p ≤ 0.01 vs Ctrl; * = p ≤ 0.01 vs fibroblasts.
Figure 2.
Effect of growing concentrations (from 10 to 250 µg/ml) of MURG chestnut pericarp extract on viability of normal cells (fibroblasts), and of colon (SW48 and RKO), breast (MCF7) and melanoma (B16F10) cancer cells. # = p ≤ 0.01 vs Ctrl; * = p ≤ 0.01 vs fibroblasts.
Figure 3.
Effect of growing concentrations (from 10 to 250 µg/ml) of LOCG chestnut pericarp extract on viability of normal cells (fibroblasts), and of colon (SW48 and RKO), breast (MCF7) and melanoma (B16F10) cancer cells. # = p ≤ 0.01 vs Ctrl; * = p ≤ 0.01 vs fibroblasts.
Figure 3.
Effect of growing concentrations (from 10 to 250 µg/ml) of LOCG chestnut pericarp extract on viability of normal cells (fibroblasts), and of colon (SW48 and RKO), breast (MCF7) and melanoma (B16F10) cancer cells. # = p ≤ 0.01 vs Ctrl; * = p ≤ 0.01 vs fibroblasts.
Figure 4.
Effect of growing concentrations (from 10 to 250 µg/ml) of ILDP chestnut pericarp extract on viability of normal cells (fibroblasts), and of colon (SW48 and RKO), breast (MCF7) and melanoma (B16F10) cancer cells. # = p ≤ 0.01 vs Ctrl; * = p ≤ 0.01 vs fibroblasts.
Figure 4.
Effect of growing concentrations (from 10 to 250 µg/ml) of ILDP chestnut pericarp extract on viability of normal cells (fibroblasts), and of colon (SW48 and RKO), breast (MCF7) and melanoma (B16F10) cancer cells. # = p ≤ 0.01 vs Ctrl; * = p ≤ 0.01 vs fibroblasts.
Figure 5.
Effect of growing concentrations (from 10 to 250 µg/ml) of COEV chestnut pericarp extract on viability of normal cells (fibroblasts), and of colon (SW48 and RKO), breast (MCF7) and melanoma (B16F10) cancer cells. # = p ≤ 0.01 vs Ctrl; * = p ≤ 0.01 vs fibroblasts.
Figure 5.
Effect of growing concentrations (from 10 to 250 µg/ml) of COEV chestnut pericarp extract on viability of normal cells (fibroblasts), and of colon (SW48 and RKO), breast (MCF7) and melanoma (B16F10) cancer cells. # = p ≤ 0.01 vs Ctrl; * = p ≤ 0.01 vs fibroblasts.
Figure 6.
Effect of growing concentrations (from 10 to 250 µg/ml) of MARRV chestnut pericarp extract on viability of normal cells (fibroblasts), and of colon (SW48 and RKO), breast (MCF7) and melanoma (B16F10) cancer cells. # = p ≤ 0.01 vs Ctrl; * = p ≤ 0.01 vs fibroblasts.
Figure 6.
Effect of growing concentrations (from 10 to 250 µg/ml) of MARRV chestnut pericarp extract on viability of normal cells (fibroblasts), and of colon (SW48 and RKO), breast (MCF7) and melanoma (B16F10) cancer cells. # = p ≤ 0.01 vs Ctrl; * = p ≤ 0.01 vs fibroblasts.
Table 1.
Total phenolics (TP), total flavonoids (TF), condensed tannins (CT), and antioxidant capacity (TEAC) determined by DPPH, ABTS and by electrochemical method (Cyclic Voltammetry), in the extracts of the pericarp chestnut samples.
Table 1.
Total phenolics (TP), total flavonoids (TF), condensed tannins (CT), and antioxidant capacity (TEAC) determined by DPPH, ABTS and by electrochemical method (Cyclic Voltammetry), in the extracts of the pericarp chestnut samples.
Accessions or variety |
T °C |
Total Phenols |
Total Flavonoids |
Condensed Tannins |
DPPH |
ABTS |
CV |
mg GAE g-1 DW |
mg CE g-1 DW |
mg CE g-1 DW |
mmol TEAC 100 g-1 DM |
AUC (µC) |
MURG |
20 95 |
39.58 ± 1.69 37.35 ± 0.64 |
18.69 ± 0.42* 16.52 ± 0.14* |
9.10 ± 0.72 9.20 ± 0.20 |
24.29 ± 1.16* 31.77 ± 2.40* |
33.33 ± 1.24 34.02 ± 0.67 |
3.02 ± 0.12* 2.04 ± 0.07* |
LOCG |
20 95 |
44.33 ± 2.89 40.10 ± 2.16 |
12.92 ± 1.70* 16.44 ± 2.3* |
6.37 ± 1.17 7.55 ± 1.38 |
23.91 ± 1.34 27.52 ± 2.84 |
31.17 ± 0.31 29.57 ± 0.92 |
2.16 ± 0.13* 2.97 ± 0.19* |
ILDP |
20 95 |
42.96 ± 1.25 38.92 ± 2.89 |
11.37 ± 1.14* 16.26 ± 1.62* |
7.05 ± 1.25 7.99 ± 0.96 |
27.20 ± 2.89 28.17 ± 2.39 |
35.71 ± 1.50 34.51 ± 0.91 |
3.15 ± 0.15 3.17 ± 0.31 |
COEV |
20 95 |
25.06 ± 0.46 22.70 ± 0.43 |
6.38 ± 0.21* 9.29 ± 1.66* |
4.73 ± 0.59 4.02 ± 0.51 |
15.31 ± 0.36* 20.07 ± 2.94* |
21.03 ± 0.37* 25.11 ± 2.49* |
1.52 ± 0.37 1.87 ± 0.28 |
MARRV |
20 95 |
15.04 ± 3.38* 31.47 ± 1.58* |
4.33 ± 1.73 3.47 ± 0.68 |
1.28 ± 0.11* 3.53 ± 0.09* |
9.12 ± 1.74* 14.22 ± 0.24* |
11.60 ± 0.20* 18.59 ± 0.05* |
2.61 ± 0.20* 3.78 ± 0.25* |
A x T |
|
# |
# |
n.s. |
# |
# |
# |
Table 2.
Main phenolic compounds (mg g−1 DM) quantified by HPLC analysis in the pericarp extracts of the four chestnut accessions and of the marron variety.
Table 2.
Main phenolic compounds (mg g−1 DM) quantified by HPLC analysis in the pericarp extracts of the four chestnut accessions and of the marron variety.
Phenolic compound |
T °C |
MURG |
LOCG |
ILDP |
COEV |
MARRV |
Gallic acid |
20 95 |
0.402 ± 0.003* 0.300 ± 0.007* |
0.553 ± 0.001* 0.390 ± 0.027* |
0.929 ± 0.125* 0.349 ± 0.025* |
0.299 ± 0.022 0.280 ± 0.029 |
0.131 ± 0.040* 0.255 ± 0.009* |
Ellagic acid |
20 95 |
2.864 ± 0.032* 0.573 ± 0.019* |
4.732 ± 0.190* 0.727 ± 0.090* |
4.469 ± 0.492* 0.684 ± 0.075* |
3.395 ± 0.434* 0.363 ± 0.050* |
1.659 ± 0.068* 0.869 ± 0.033* |
Vescalagin |
20 95 |
0.525 ± 0.058* 0.768 ± 0.007* |
0.406 ± 0.013* 0.998 ± 0.069* |
0.364 ± 0.037* 0.629 ± 0.012* |
0.237 ±0.001* 0.409 ±0.025* |
0.168 ± 0.029* 0.463 ± 0.007* |
Castalagin |
20 95 |
0.631 ± 0.041 0.714 ± 0.015 |
0.449 ± 0.021* 0.980 ± 0.167* |
0.364 ± 0.037* 0.629 ± 0.012* |
0.246 ± 0.012* 0.419 ±0.064* |
0.238 ±0.060 0.374 ± 0.050 |
Catechin |
20 90 |
0.219 ± 0.008 0.231 ± 0.009 |
0.261 ± 0.022 0.268 ± 0.016 |
0.564 ± 0.028* 0.248 ± 0.002* |
0.161 ± 0.005 0.180 ± 0.017 |
0.199 ± 0.027* 0.670 ± 0.013* |
Epicatechin |
20 95 |
0.595 ± 0.077 0.665 ± 0.016 |
0.271 ± 0.033* 2.232 ± 0.279* |
0.732 ± 0.067 0.900 ± 0.009 |
0.287 ± 0.044 0.285 ± 0.065 |
0.204 ±0.011* 0.521 ± 0.008* |
Epigallocatechin |
20 95 |
0.067 ± 0.012 0.052 ± 0.015 |
0.081 ± 0.011 0.063 ± 0.001 |
0.091 ± 0.020 0.075 ± 0.003 |
0.055 ± 0.001 0.041 ± 0.000 |
0.046 ± 0.004 0.056 ± 0.006 |
Table 3.
Redox potential values of standards of the seven main phenolic compounds found in the chestnut epicarp extracts of MURG, ILDP, LOCG, COEV and MARRV.
Table 3.
Redox potential values of standards of the seven main phenolic compounds found in the chestnut epicarp extracts of MURG, ILDP, LOCG, COEV and MARRV.
Phenolic compound |
Redox potential (V) |
Reference |
Gallic acid |
+ 0.391 + 0.180 |
[26,43] |
Ellagic acid |
+ 0.367 |
[26] |
Vescalagin |
+ 0.384 |
[26] |
Castalagin |
+ 0.384 |
[26] |
Catechin |
+ 0.391 + 0.300 + 0.120 |
[26,43,44] |
Epicatechin |
+ 0.120 |
[44] |
Epigallocatechin |
+ 0.080 |
[44] |